Search This Blog

Thursday, January 29, 2015

Scoring Progress Against Cancer: New Tool Measures Cancer Progress to Help Inform Research and Policy Decisions (NYSE:LLY)

WASHINGTON, Jan. 29, 2015 /PRNewswire/ -- On the eve of World Cancer Day 2015, amidst the ongoing cost-of-cancer-care debate, PACE (Patient Access to Cancer care Excellence), a Lilly Oncology initiative, is launching the PACE Continuous Innovation Indicators™ (CII). CII is the first evidence-based, customizable online tool to review progress against cancer over time—initially covering 12 cancer types. The purpose of the tool is to inform public policy reforms and other efforts to accelerate continuous innovation against cancer.



Scoring Progress Against Cancer: New Tool Measures Cancer Progress to Help Inform Research and Policy Decisions (NYSE:LLY)
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)